![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Stryker Receives FDA Clearance for Cementless Knee Implant
Stryker Receives FDA Clearance for Cementless Knee Implant
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
October 18, 2017
Stryker's Joint Replacement division received FDA 510(k) market clearance for its Cementless Mako Total Knee with Triathlon Tritanium.
The implant combines the motion features of Stryker's Triathlon knee implant with a highly porous biologic fixation technology.
The device’s tibial baseplate and metal-backed patella components are made using proprietary AMagine additive manufacturing technology.
Upcoming Events
-
21Oct